Search Results - "Angelberger, S"

Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors by Papay, P., Primas, C., Eser, A., Novacek, G., Winkler, S., Frantal, S., Angelberger, S., Mikulits, A., Dejaco, C., Kazemi-Shirazi, L., Vogelsang, H., Reinisch, W.

“…Patients treated with TNF-α inhibitors (TNFi) are at high risk of reactivation of latent tuberculosis (LTB). Prospective studies on monitoring of TB…”
Get full text

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study by Sjöberg, Mats, Walch, Andrea, Meshkat, Mina, Gustavsson, Anders, Järnerot, Gunnar, Vogelsang, Harald, Hertervig, Erik, Novacek, Gottfried, Friis‐Liby, Ingalill, Blomquist, Lars, Angelberger, Sieglinde, Karlen, Per, Grännö, Christer, Vilien, Mogens, Ström, Magnus, Verbaan, Hans, Hellström, Per M., Dejaco, Clemens, Magnuson, Anders, Halfvarson, Jonas, Reinisch, Walter, Tysk, Curt

“…Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid‐refractory, severe attacks of ulcerative colitis (UC). There are no…”
Get full text

The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease by Eser, A., Papay, P., Primas, C., Pernicka, E., Harrer, M., Dejaco, C., Novacek, G., Lichtenberger, C., Angelberger, S., Kazemi, L., Mikulits, A., Vogelsang, H., Reinisch, W.

“…Aliment Pharmacol Ther 2012; 35: 292–299 Summary Background  Antibodies to Saccharomyces cerevisiae (ASCA) are highly prevalent in sera of patients with…”
Get full text

Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy by Angelberger, S, Reinisch, W, Dejaco, C

“…Thioguanine was discontinued and after the patient had failed to respond to intravenous prednisolone at a dose of 75 mg for nine days, abortion was discussed…”
Get full text

Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis by Dejaco, C, Oesterreicher, C, Angelberger, S, Püspök, A, Birner, P, Poetzi, R, Gangl, A, Oberhuber, G

“…It is generally believed that making a correct histological diagnosis of colitis at colonoscopy requires segmental mucosal biopsies, information on the…”
Get more information

Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology by Angelberger, S, Campregher, C, Fuchssteiner, H, Gasche, C, Gröchenig, H-P, Haas, T, Kazemi-Shirazi, L, Mayer, A, Miehsler, W, Platzer, R, Reinisch, W, Steiner, P, Tilg, H, Tillinger, W, Vogelsang, H, Novacek, G

“…Patients with ulcerative colitis and Crohn's colitis are at increased risk of colorectal cancer (CRC). This risk is dependent on the duration and extent of…”
Get more information

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial by Reinisch, Walter, Angelberger, Sieglinde, Petritsch, Wolfgang, Shonova, Olga, Lukas, Milan, Bar-Meir, Simon, Teml, Alexander, Schaeffeler, Elke, Schwab, Matthias, Dilger, Karin, Greinwald, Roland, Mueller, Ralph, Stange, Eduard F, Herrlinger, Klaus R

“…The aim of the study was to compare azathioprine versus mesalazine tablets for the prevention of clinical recurrence in patients with postoperative Crohn's…”
Get more information

Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels by Angelberger, Sieglinde, Schaeffeler, Elke, Teml, Alexander, Petritsch, Wolfgang, Shonova, Olga, Lukas, Milan, Bar-Meir, Simon, Dilger, Karin, Greinwald, Roland, Mueller, Ralph, Stange, Eduard F, Herrlinger, Klaus R, Schwab, Matthias, Reinisch, Walter

“…The value of azathioprine metabolites (6-thioguanine nucleotides [6-TGN]) in monitoring clinical treatment response is still controversially discussed. Data…”
Get full text

P699 Temporal bacterial community dynamics vary among ulcerative colitis patients after faecal microbiota transplantation by Angelberger, S., Reinisch, W., Makristathis, A., Lichtenberger, C., Dejaco, C., Papay, P., Novacek, G., Trauner, M., Loy, A., Berry, D.

Get full text

P608 Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial by Reinisch, W., Angelberger, S., Petritsch, W., Shonova, O., Lukas, M., Greinwald, R., Mueller, R., Stange, E.F., Herrlinger, K.

Get full text

P381 Role of fecal calprotection in predicting ileocolonic endoscopic recurrence in postoperative Crohn's disease by Primas, C., Frühwald, G., Angelberger, S., Allerstorfer, D., Papay, P., Eser, A., Gratzer, C., Dejaco, C., Reinisch, W., Novacek, G., Vogelsang, H.

Get full text

P641 Health, marital and occupational state of patients with Crohn's disease relative to their non-IBD affected siblings and peers by Gratzer, C., Reinisch, W., Vogelsang, H., Dejaco, C., Angelberger, S., Eser, A., Christian, P., Papay, P., Urach, C., Vavrovsky, A., Novacek, G.

Get full text

P605 Adalimumab (ADA) and infliximab (IFX) therapy during pregnancy in IBD: a prospective assessment of outcome, safety and cord blood levels by Traussnigg, S., Eser, A., Primas, C., Papay, P., Gratzer, C., Angelberger, S., Mikulits, A., Reinisch, W., Trauner, M., Vogelsang, H., Novacek, G., Dejaco, C.

Get full text

P348 Retesting for latent tuberculosis in patients with inflammatory bowel disease after exposure to biologics by Papay, P., Primas, C., Eser, A., Winkler, S., Novacek, G., Angelberger, S., Mikulits, A., Vogelsang, H., Reinisch, W.

Get full text

P186 Granulocyte activation as measured by CD64 expression on PMNs reflects inflammatory load in inflammatory bowel disease by Eser, A., Primas, C., Papay, P., Lichtenberger, C., Mikulits, A., Angelberger, S., Novacek, G., Vogelsang, H., Tillinger, W., Reinisch, W.

Get full text

P374 Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis (UC) by Angelberger, S., Lichtenberger, C., Gratzer, C., Papay, P., Primas, C., Eser, A., Mikulits, A., Dejaco, C., Novacek, G., Vogelsang, H., Reinisch, W.

Get full text

Association Between NOD2/CARD15 Gene Variants and Response to Antibiotics in Perianal Fistulizing Crohn's Disease by Angelberger, S., Schwab, M., Dejaco, C., Waldhoer, T., Lichtenberger, C., Harrer, M., Schaeffeler, E., Vogelsang, H., Reinisch, W.

Get full text

P141 BREASTFEEDING DURING MAINTENANCE AZATHIOPRINE TREATMENT (AZA) IN PATIENTS WITH CROHN'S DISEASE (CD) by Angelberger, S., Reinisch, W., Messerschmidt, A., Miehsler, W., Novacek, G., Vogelsang, H., Dejaco, C.

Get full text

P130 AWARENESS OF CROHN'S DISEASE AND ULCERATIVE COLITIS IN THE AUSTRIAN POPULATION by Angelberger, S., Vogelsang, H., Novacek, G., Miehsler, W., Dejaco, C., Gangl, A., Reinisch, W.

Get full text

Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy by Angelberger, S, Reinisch, W, Dejaco, C

Get full text